雅虎香港 搜尋

登入

  1. 相關搜尋:

搜尋結果

  1. pubmed.ncbi.nlm.nih.gov › 29518013Immunogenicity and Safety of the New Inactivated ...

    2018年3月8日 · Vaxigrip Tetra is well tolerated, has aroused no safety concerns, and is recommended for the active immunization of individuals aged ≥6 months. In addition, preliminary data confirm its immunogenicity and safety even in children aged 6-35 months and its immunogenicity in older subjects (aged 66-80 years).

  2. www.tga.gov.au › sites › defaultAttachment: Product Information for Inactivated quadrivalent ...

    Attachment 1: Product AusPAR - Vaxigrip Tetra - Inactivated quadrivalent influenza vaccine (split virion) - Sanofi-Aventis Australia Pty Ltd - PM-2018-00583-1-2 FINAL 19 December 2019. This

  3. www.ncbi.nlm.nih.gov › pmc › articles4. A Novel Quadrivalent Inactivated Influenza Vaccine: ...

    2018年3月8日 · Vaccines (Basel). 2018 Mar; 6 (1): 14. Published online 2018 Mar 8. doi: 10.3390/vaccines6010014. PMCID: PMC5874655. PMID: 29518013. Immunogenicity and Safety of the New Inactivated Quadrivalent Influenza Vaccine Vaxigrip Tetra: Preliminary Results in Children ≥6 Months and Older Adults.

    • Emanuele Montomoli, Alessandro Torelli, Ilaria Manini, Elena Gianchecchi
    • 10.3390/vaccines6010014
    • 2018
    • Vaccines (Basel). 2018 Mar; 6(1): 14.

  4. www.sanofi.com › assets › countriesPROFESSIONAL INFORMATION FOR VAXIGRIP TETRA - Sanofi

    VAXIGRIP TETRA is indicated for the prevention of influenza disease caused by the two influenza. virus subtypes and the two influenza B virus types contained in the vaccine for: active immunisation of adults, including pregnant women, and children from 6 months of age. and older,

  5. www.tga.gov.au › sites › defaultAustralian Public Assessment Report for Inactivated ...

    AusPAR - Vaxigrip Tetra - Inactivated quadrivalent influenza vaccine (split virion) - Sanofi-Aventis Australia Pty Ltd - PM-2018-00583-1-2 FINAL 19 December 2019 Page 4 of 30

  6. hk-medicare.com › vaxigrip-tetra流感疫苗預約 (全新2024 四價流感疫苗) - 香港綜合醫療保健中心 ...

    Watch on. 衞生署衞生防護中心 – 增強流感免疫力，不要等，快打針，防流感. 流感疫苗預約 – 2024 四價流感疫苗 (Vaxigrip Tetra) 藥廠：法國 Sanofi. 接種針數：共1針. 適合人群：滿6個月或以上人士，9歲以上：接種 1 針 ， 9歲以下且從未注射過流感疫苗：接種 2 針 (相隔至少1個月) 疫苗成分：四種流感病毒. 2023/24 季度，疫苗可預防疾病科學委員會建議的四價流感疫苗成分包括以下 4 種流感病毒（2種類甲型及 2種類乙型流感病毒）： A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238)

  1. 相關搜尋

    vaxigrip tetra 2018-2019流感針